Statistical evaluation of the RF IgM-positive participants (DLBCL patients and healthy controls) showed a significantly higher frequency of ACPA-positive DLBCL patients than healthy controls (1.77% versus 0%, p = 0.043). The gene discussed is PRTN3; the disease is diffuse large B-cell lymphoma.